Journals / European Journal of Research in Dentistry / 2019 / Cilt: 3 - Sayı: 2

A Sublingual Neurofibroma: A Case Report

Pages
109–114
Publication Date
2019-12-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report we aim to present our approach of treatment with intent to meet patient’s preprosthetic demands by performing an incisional biopsy on a sublingual neurofibroma and review the current literature in terms of diagnostic criteria, clinical features, accompanying impairments and treatment modalities.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neurofibromatosis is a genetically inherited, autosomal dominant disorder.
📊
Key Findings & Data:Deletions or mutations on chromosomes 17 and 22 precipitate to neurofibromatosis and there are genetically two types of the it as Type 1 and Type 2.
💡
Conclusion & Impact:In this case report we aim to present our approach of treatment with intent to meet patient’s preprosthetic demands by performing an incisional biopsy on a sublingual neurofibroma and review the current literature in terms of diagnostic criteria, clinical features, accompanying impairments and treatment modalities.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:sublingual · neurofibroma

Abstract

Neurofibromatosis is a genetically inherited, autosomal dominant disorder. Deletions or mutations on chromosomes 17 and 22 precipitate to neurofibromatosis and there are genetically two types of the it as Type 1 and Type 2. Neurofibromatosis Type 1 is relevant with the abnormalities on chromosome 17. In the affected population, the incidence of oral manifestation is as high as 92%, and the tongue is the most common involved site. Due to the lack of neurofibromin, which is encoded by the NF1 gene located on chromosome 17 and acts as a tumor suppressor protein, neurofibromas are frequently diagnosed on the tongue as nodular growths or diffuse macroglossia in the oral cavity. In this case report we aim to present our approach of treatment with intent to meet patient’s preprosthetic demands by performing an incisional biopsy on a sublingual neurofibroma and review the current literature in terms of diagnostic criteria, clinical features, accompanying impairments and treatment modalities.

Özet

Nörofibromatozis genetik olarak aktarılan, otozomal dominant bir hastalıktır. Hastalığın oluşumuna 17. Ve 22. kromozomlardaki delesyonlar (silinme) veya mutasyonlar sebep olmakta ve hastalığın tip 1 ve tip 2 olmak üzere iki türü bulunmaktadır. Nörofibromatozis Tip 1, 17. kromozomdaki anomalilerden kaynaklanmaktadır. Etkilenen popülasyonda oral bulguların görülme sıklığı %92’ye kadar yükselmektedir. Dil, oral bölgede en sık etkilenen organdır. Hasta bireylerde, tümör baskılayıcı bir protein olan ve 17. kromozom üzerinde yer alan, NF1 geni tarafından kodlanan nörofibromin üretilmediği için oral kavitede sıklıkla dilde nodüler büyümeler şeklinde veya diffüz makroglossi tarzında nörofibromalar görülmektedir. Bu olgu sunumunda, Nörofibromatozis Tip 1 tanılı hastada bir sublingual nörofibromaya insizyonel biyopsi ile preprotetik amaçlı tedavi yaklaşımımızı sunmayı ve mevcut literatürü tanı kriterleri, klinik özellikler, eşlik eden bozukluklar ve tedavi yöntemleri açısından gözden geçirmeyi amaçladık.

🔖

Cite This Article

ALTAN, A., ERDİL, A., AKBULUT, N. (2019). A Sublingual Neurofibroma: A Case Report. European Journal of Research in Dentistry, Cilt: 3 - Sayı: 2, 109–114. https://ajindex.com/articles/757885

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ba MR, Caltabiano R, Polizzi A. Early history of the different forms of neurofibromatosis from ancient Egypt to the British Empire and beyond: First descriptions, medical curiosities, misconceptions, landmarks, and the persons behind the syndromes. 2018
  2. (June 2017):515-550. doi:10.1002/ajmg.a.38486 2. Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997
  3. 278(1):51-57. 3. MacCollin M, Chiocca EA, Evans DG, et al. Diagnostic criteria for schwannomatosis. Neurology. 2005
  4. 64(11):1838-1845. doi:10.1212/01.WNL.0000163982.78900.AD 4. Patel NB, Stacy GS. Musculoskeletal manifestations of neurofibromatosis type 1. AJR Am J Roentgenol. 2012
  5. 199(1):W99-106. doi:10.2214/AJR.11.7811 5. D’Ambrosio JA, Langlais RP, Young RS. Jaw and skull changes in neurofibromatosis. Oral Surgery, Oral Med Oral Pathol. 1988
  6. 66(3):391-396. doi:10.1016/0030-4220(88)90252-6 6. Bekisz O, Darimont F, Rompen EH. Diffuse but unilateral gingival enlargement associated with von Recklinghausen neurofibromatosis: a case report. J Clin Periodontol. 2000
  7. 27(5):361-365. 7. Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol. 2007
  8. 6(4):340-351. doi:10.1016/S1474-4422(07)70075-3 8. DeBella K, Szudek J, Friedman JM. Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000
  9. 105(3):608-614. doi:10.1542/peds.105.3.608 9. Vincent SD, Williams TP. Mandibular abnormalities in neurofibromatosis. Case report and literature review. Oral Surg Oral Med Oral Pathol. 1983
  10. 55(3):253-258. 10. Oliveira MG De, Moure SP. NF1 diagnosis criteria and associated sarcomatous tumor review of the literature and case report. 2008:231-235. doi:10.1007/s10006-008-0137-1 11. Shapiro SD, Abramovitch K, Van Dis ML, et al. Neurofibromatosis: oral and radiographic manifestations. Oral Surg Oral Med Oral Pathol. 1984
  11. 58(4):493-498. http://www.ncbi.nlm.nih.gov/pubmed/6436765. Accessed February 4, 2019. 12. van Damme PA, Mooren RE. Differentiation of multiple giant cell lesions, Noonan-like syndrome, and (occult) hyperparathyroidism. Case report and review of the literature. Int J Oral Maxillofac Surg. 1994
  12. 23(1):32-36. 13. Cao H, Klein NAOD, Goodwin AF. A review of craniofacial and dental findings of the RASopathies. 2017
  13. 20(February):32-38. doi:10.1111/ocr.12144 14. Trovo-Marqui AB, Tajara EH. Neurofibromin: a gen